Cyvex Earns Patent for Cognitive Health Fisetin Ingredient
Cyvex Nutrition has been issued a Notice of Allowance from the U.S. Patent and Trademark Office for a patent relating to its use of Cognisetin, a fisetin-based ingredient believed to enhance long-term memory.
Cyvex Nutrition (Irvine, CA) has been issued a Notice of Allowance from the U.S. Patent and Trademark Office for a patent relating to its use of Cognisetin, a fisetin-based ingredient believed to enhance long-term memory.
The patent relates to the ingredient’s use of flavonoids to enhance memory.
“The patent describes fisetin as a neuroprotector capable of generating neuron cells in the presence of damage, promoting antioxidant synthesis, and reducing overactive brain-and spinal cord-specific immune defenses that contribute to age-related decline and/or conditions,” said the company in a recent statement.
Matt Phillips, president and CEO of Cyvex Nutrition says that the patent “…validates Cognisetin’s status as a genuinely novel ingredient with a clinically-backed cognitive health benefit.”
Driving Sustainability in Nutraceuticals: How Ingredient Brands Are Raising the Bar
April 26th 2024Health-minded consumers, especially Generation Z, value nutraceutical companies with sustainability embedded into their corporate philosophy—from product development to packaging. This article discusses how responsible companies are responding to the consumer call for greater sustainability by implementing environmentally friendly manufacturing practices that ultimately lead to waste reduction, improved supplier communications and lower supply chain risk. Those who have taken steps to demonstrate a genuine commitment to sustainability are standing out with improved outcomes for all.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
